22 May 2013
Keywords: pfizer, initiates, ph, trial, motilin, agonist, licensed
Article | 13 August 2007
Pfizer has initiated a Phase I clinical trial of its selective and potent motilin receptor agonist PF-04548043. The drug, which ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
13 August 2007
21 May 2013
© 2013 thepharmaletter.com